HireQuest carries limited sell-side coverage, with available targets clustered tightly. Barrington’s Kevin Steinke and D.A. Davidson both maintain a $19 price target after raising their figures from $15 following stronger second-quarter results. That $19 level offers less than 5% upside from the current price, so it does not meet the minimum threshold for a meaningful target question. As a result, the discussion here uses a fallback objective drawn from observable public technical levels: the 52-week high near $20.84 reached in late September 2026 and the round $21 level just above it. This serves as a market-structure reference rather than an analyst consensus valuation.
Shares last closed near $18.25, producing a market capitalization around $253 million. Reaching $21 would require a move of roughly 15%, which is substantial for a small-cap name over a near-term horizon. The route would likely involve retesting the $20.84 prior high before any push toward $21. The stock has already posted a sharp rebound—up about 76% year-to-date and near 90% over the trailing year—after rising from a 52-week low of $7.38, so much of the recovery is already behind it. I also checked this using Tickeron’s AI Daily Buy/Sell Signals to see how the recent price action compares with broader market signals.
The strongest fundamental case centers on an improving demand environment. After an extended staffing downturn, HireQuest posted year-over-year revenue growth in mid-2026, and management has pointed to strengthening demand and market-share gains. The company runs a capital-light franchise model, carries essentially no debt, and returns cash through a regular dividend plus a $20 million share repurchase program. Any pickup in labor-market activity, successful small acquisitions, or renewed progress on strategic deals could bolster confidence and help retest prior highs.
The clearest near-term hurdle is the third-quarter 2026 report, where GAAP EPS fell well below expectations even though revenue came in ahead of forecasts. Separately, the company’s proposal to acquire assets of TrueBlue (TBI) PeopleReady segment was rejected, removing a potential catalyst and leaving some uncertainty around the acquisition strategy. Staffing remains inherently cyclical and sensitive to hiring demand, interest rates, and broader economic conditions. In addition, HQI is a thinly traded small cap, which can produce sharp price swings and make sustained rallies more difficult to sustain.
The main reference points remain the 52-week high near $20.84 and the 52-week low near $7.38. The $20.84 area serves as the primary resistance zone, with $21 just above it acting as a psychological ceiling. On the downside, recent consolidation near $17 and the mid-teens has offered support. A decisive move above the prior high on higher volume would stand out as a structural signal, while failure to hold recent support could indicate the recovery is losing momentum.
Analyst targets generally reflect a 12-month research horizon, though the $21 objective here is a technical milestone without a fixed timeline. Investors should track quarterly earnings and guidance, franchise and system-wide sales trends, any renewed acquisition activity, analyst target revisions, and broader labor-market data that influences staffing demand. Dividend declarations and buyback execution also provide useful signals of management confidence. From what I see, watching the $20.84 resistance zone closely will be important for gauging direction.
Tickeron’s AI Daily Buy/Sell Signals apply artificial intelligence to monitor thousands of stocks and ETFs in real time. The tool generates Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis, helping traders identify opportunities, track positions, and spot trend changes more efficiently than manual screening alone. For anyone following HQI or the wider market, these signals provide a systematic approach to staying ahead of evolving conditions.
The $21 objective is a technical reference point tied to HireQuest’s prior 52-week high rather than an analyst-issued target, implying roughly 15% upside from the current price near $18.25. The supportive case rests on a genuine demand recovery, share gains, a debt-free balance sheet, and shareholder-friendly capital returns. The opposing case rests on a recent earnings miss, a rejected acquisition, sector cyclicality, and small-cap volatility. Published analyst targets at $19 sit below the $21 milestone, highlighting the gap between sell-side expectations and the technical objective. There is no guarantee of any outcome, and investors should monitor earnings, demand trends, and the $20.84 resistance zone as the clearest signals of direction.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
HQI moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend. In 43 of 54 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 80%.
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on HQI as a result. In 79 of 108 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.
The Moving Average Convergence Divergence (MACD) for HQI just turned positive on November 04, 2026. Looking at past instances where HQI's MACD turned positive, the stock continued to rise in 36 of 47 cases over the following month. The odds of a continued upward trend are 77%.
The 10-day moving average for HQI crossed bullishly above the 50-day moving average on November 12, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 15 of 24 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.
Following a +3.58% 3-day Advance, the price is estimated to grow further. Considering data from situations where HQI advanced for three days, in 177 of 249 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HQI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
HQI broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for HQI entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. HQI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 64 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 84 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.548) is normal, around the industry mean (4.795). P/E Ratio (29.814) is within average values for comparable stocks, (1.381). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (1.448). Dividend Yield (0.014) settles around the average of (1.499) among similar stocks. HQI's P/S Ratio (7.576) is very high in comparison to the industry average of (0.884).
The Tickeron Profit vs. Risk Rating rating for this company is 95 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HQI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a company, which engages in providing temporary staffing services
Industry OtherConsumerServices